Evaluating Thermotherapy for Treating Cutaneous Leishmaniasis in Primary Healthcare Centers of East Gurage Zone, Ethiopia
Led by Armauer Hansen Research Institute, Ethiopia · Updated on 2026-10-16
103
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of thermotherapy TT as a treatment for cutaneous leishmaniasis CL in primary healthcare centers in the Sodo and South Sodo districts of Ethiopia. The study aims to determine whether using TT in these health centers is practical, acceptable, and suitable, as well as how effective TT is for treating CL in this setting. The project follows a phased approach, including training healthcare staff, piloting the intervention, and expanding treatment while assessing feasibility and cost-effectiveness.
Thermotherapy treatment involves applying radio frequency-induced heat using the ThermoMed device, which heats the affected skin area to 50C for 30 seconds. Treatment may be administered up to twice based on patient response at four and eight weeks after the initial treatment. The study includes health centers that do not provide TT as a comparison group, where patients with CL are observed for up to three months before referral for thermotherapy.
Participants receive training for diagnosis and management of CL and undergo assessments including digital photography and skin scraping for PCR confirmation. Patients treated with TT are monitored every four weeks up to 90 days for treatment response and again at 180 days to check for relapse. The study also evaluates the accuracy of healthcare staff in diagnosing CL and monitors treatment success, feasibility, acceptability, and adherence to training throughout the process. Total participation may last up to 180 days for treated patients.
CONDITIONS
Brief Title
Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
Research Team
D
Dawit Ejigu, MD, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Lesions not adjacent to ear, nose, eyes, lips, or mucosal membranes
Four or fewer cutaneous leishmaniasis lesions
Ability to provide written informed consent
You will not qualify if you...
Any condition that prevents following the study treatment or attending follow-up visits
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 8 weeks
Participants receive thermotherapy using the ThermoMed device to heat skin lesions to 50°C for 30 seconds. Treatment may be repeated once depending on response at 4 or 8 weeks.
Visits every 4 weeks
Follow-up
Duration - Up to 180 days
Participants are monitored for treatment response and possible relapse of skin lesions up to 180 days after initial treatment.
Visits on day 90 and day 180
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Comparing Ciprofloxacin and Sodium Stibogluconate Injections for Treating Cutaneous Leishmaniasis in Adults
Evaluating Thermotherapy for Treating Cutaneous Leishmaniasis in Primary Healthcare Centers of East Gurage Zone, Ethiopia
Effectiveness of Intralesional Levofloxacin Injections for Treating Cutaneous Leishmaniasis Lesions in Adults
Study of Intralesional Metronidazole Injection to Treat Cutaneous Leishmaniasis Lesions in Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Feasibility of integrating thermotherapy (TT) for the treatment of Cutaneous Leishmaniasis into the primary healthcare facilities in east gurage zone, ethiopia: a protocol for an implementation research study.